AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 50 filers reported holding AVROBIO INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,402,000 | +7.1% | 244,032 | 0.0% | 0.08% | -33.6% |
| Q3 2020 | $3,177,000 | -42.7% | 244,032 | -23.2% | 0.12% | -42.2% |
| Q2 2020 | $5,542,000 | +12.1% | 317,579 | 0.0% | 0.21% | -8.3% |
| Q1 2020 | $4,942,000 | -22.7% | 317,579 | 0.0% | 0.23% | -9.8% |
| Q4 2019 | $6,393,000 | -20.3% | 317,579 | -44.1% | 0.26% | -47.7% |
| Q3 2019 | $8,024,000 | +79.4% | 568,294 | +106.7% | 0.49% | +89.9% |
| Q2 2019 | $4,472,000 | -32.4% | 275,000 | -8.3% | 0.26% | -42.5% |
| Q1 2019 | $6,615,000 | -70.7% | 300,000 | -77.9% | 0.45% | -75.6% |
| Q4 2018 | $22,607,000 | -70.8% | 1,357,784 | -9.0% | 1.84% | -63.5% |
| Q3 2018 | $77,431,000 | +79.8% | 1,492,784 | -1.0% | 5.03% | +57.9% |
| Q2 2018 | $43,062,000 | – | 1,507,783 | – | 3.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |